These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24080886)

  • 1. [Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides].
    García-Vázquez E; Albendín H; Hernández-Torres A; Canteras M; Yagüe G; Ruiz J; Gómez J
    Rev Esp Quimioter; 2013 Sep; 26(3):203-13. PubMed ID: 24080886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation].
    Hernández-Roca JJ; García-Vázquez E; Hernández A; Canteras M; Herrero JA; Cascales E; Mené-Fenor E; Gómez-Gómez J
    Rev Esp Quimioter; 2013 Jun; 26(2):119-27. PubMed ID: 23817650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.
    Pinholt M; Ostergaard C; Arpi M; Bruun NE; Schønheyder HC; Gradel KO; Søgaard M; Knudsen JD;
    Clin Microbiol Infect; 2014 Feb; 20(2):145-51. PubMed ID: 23647880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.
    Lu CL; Chuang YC; Chang HC; Chen YC; Wang JT; Chang SC
    J Antimicrob Chemother; 2012 Sep; 67(9):2243-9. PubMed ID: 22618861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas.
    Caballero-Granado FJ; Cisneros JM; Luque R; Torres-Tortosa M; Gamboa F; Díez F; Villanueva JL; Pérez-Cano R; Pasquau J; Merino D; Menchero A; Mora D; López-Ruz MA; Vergara A
    J Clin Microbiol; 1998 Feb; 36(2):520-5. PubMed ID: 9466769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
    Forrest GN; Arnold RS; Gammie JS; Gilliam BL
    J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
    Sánchez-Silos RM; Pérez-Giraldo C; Blanco MT; Morán FJ; Hurtado C; Gómez-García AC
    Chemotherapy; 2001 Dec; 47(6):415-20. PubMed ID: 11786656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonization by high-level aminoglycoside-resistant enterococci in intensive care unit patients: epidemiology and clinical relevance.
    Rodríguez-Baño J; Ramírez E; Muniain MA; Santos J; Joyanes P; González F; García-Sánchez M; Martínez-Martínez L
    J Hosp Infect; 2005 Aug; 60(4):353-9. PubMed ID: 15893852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.
    Foo H; Chater M; Maley M; van Hal SJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2252-7. PubMed ID: 24744303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of 117 episodes of enterococcal bacteremia: Study of epidemiology, microbiology and antimicrobial susceptibility].
    Manassero NC; Navarro M; Rocchi M; di Bella H; Gasparotto AM; Ocaña Carrizo AV; Novillo F; Furiasse D; Monterisi A
    Rev Argent Microbiol; 2016; 48(4):298-302. PubMed ID: 27567523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
    Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
    Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
    McBride SJ; Upton A; Roberts SA
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):107-14. PubMed ID: 19916034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance.
    Shaked H; Carmeli Y; Schwartz D; Siegman-Igra Y
    Scand J Infect Dis; 2006; 38(11-12):995-1000. PubMed ID: 17148067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
    Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
    J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.
    McCracken M; Wong A; Mitchell R; Gravel D; Conly J; Embil J; Johnston L; Matlow A; Ormiston D; Simor AE; Smith S; Du T; Hizon R; Mulvey MR;
    J Antimicrob Chemother; 2013 Jul; 68(7):1505-9. PubMed ID: 23524466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.